GLOBAL CONTRACEPTIVE MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

GLOBAL CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education, Drugs & Devices, End Users And Geography | Forecast 2019-2027

Request Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

After a detailed analysis, Triton Market Research has arrived at the conclusion that the global contraceptive market is expected to display an upward trend by growing at a CAGR of 6.93% in terms of revenue from 2019 to 2027.

The increase in the use of modern contraceptive methods, rising awareness about sexual health & family planning and an increase in government initiatives are likely to drive the market during the forecast period. Healthcare providers are imparting education about contraceptive options and their advantages, disadvantages, availability, accuracy and price to provide users with the option to select the best contraceptive technique, which depends largely on their desired family size, lifestyle, desire for children and envisioned scheduling for pregnancy. 

Contraceptive devices are expected to witness lucrative growth owing to associated advantages such as fewer side effects and effective contraception. Condoms have been determined to be the most profitable sub-segment of the contraceptive devices market. Low prices and abundant product availability are two key factors expected to drive the segment growth over the forecast period. Market definition and key insights regarding the industry have been discussed within this report. Also, the regulatory framework, market attractiveness index, Porter’s five force analysis and key market strategies have been studied for the global contraceptive market. 

Market drivers comprise of growing cognizance for contraceptives, increasing usage of oral contraceptives to evade unplanned pregnancy, surge in the initiatives of the government and NGOs and growing awareness about STDs. The industry is facing market restraints like side-effects restricting the growth of contraceptives and limited access to contraceptives that obstructs the usage of contraceptives. 

Key opportunities like rising disposable incomes in emerging economies, unmet medical needs in the emerging economies and technological advancements create an opportunity for the contraceptive market. Female and male contraceptive methods have witnessed technological advancements, which are anticipated to drive the contraceptives market growth in the future.

Lack of acceptance in society is a major barrier for the contraceptives market. The socio-cultural restrictions hamper the market growth, as these are the basic beliefs of the elderly population in a few emerging economies.

Geographies that have been studied in the global contraceptive market are as follows:

•    North America: The United States and Canada

•    Europe: The United Kingdom, Germany, France, Italy, Spain, Russia and rest of Europe

•    Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and rest of Asia-Pacific

•    Latin America: Brazil, Mexico and rest of Latin America

•    The Middle East & Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and rest of the Middle East & Africa

The report on the global contraceptive market includes segmentation on the basis of age group, education, drugs & devices and end users.

O    Age group is segmented into:

•     15–24 years

•      25–34 years

•      35–44 years

•      Above 44 years

O    Education is segmented into:

•      Less than high school

•      High school graduate

•      College graduate

•      Other college degrees

O    Drugs & devices are segmented into:

•      Contraceptives drugs:

O    Oral contraceptive pills

O     Injectable contraceptives

O    Topical contraceptives

•      Contraceptive devices:

O    Male condoms

O    Female condoms

O    Diaphragms

O    Contraceptive sponges

O    Vaginal rings

O    Subdermal implants

O    Intra-uterine devices:  

•   Copper intra-uterine devices

•   Hormonal intra-uterine devices

O    End users are segmented into:

•    Households

•    Clinics

•    Hospitals

The companies engaged in the global contraceptive market are Church & Dwight Co., Inc., Agile Therapeutics, Allergan, Inc., Reckitt Benckiser PLC, SMB Corporation, Mayer Laboratories, Inc., Afaxys, Inc., Ocon Medical, Ltd., Teva Pharmaceutical Industries, Ltd., Bayer AG, Pfizer, Inc., Melbea, Cooper Surgical, Inc., Apothecus Pharmaceutical Corporation, Okamoto Industries, Inc., Pregna and Merck & Co., Inc.

The strategic analysis for each of these companies in the global contraceptive market has been covered in detail. The company market position helps to dive into the information about the key market players in this industry and how much of a hold they have on the market.


Related Reports

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027
Lifesciences

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027

Market By Offerings, Technolog ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027
Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027

Market By Therapeutics & Diagn ..

VIEW REPORT
ASIA-PACIFIC BIOSURGERY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BIOSURGERY MARKET 2019-2027

Market By Product, Application ..

VIEW REPORT
ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Applicat ..

VIEW REPORT
ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027

Market By Test Types, Technolo ..

VIEW REPORT
ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027

Market By Component, End-user ..

VIEW REPORT
ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education ..

VIEW REPORT

Table of Content

1.    CONTRACEPTIVE MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. PESTEL OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET PLAYER POSITIONING

2.7. KEY INSIGHTS

2.7.1.   ORAL CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS

2.7.2.   CONDOMS ARE THE WIDELY USED CONTRACEPTIVES DEVICE

2.7.3.   AGE GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE GLOBAL CONTRACEPTIVE MARKET

2.8. MARKET DRIVERS

2.8.1.   GROWING COGNIZANCE FOR CONTRACEPTIVES

2.8.2.   INCREASING USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY

2.8.3.   SURGE IN THE INITIATIVES OF GOVERNMENT AND NGO

2.8.4.   GROWING AWARENESS ABOUT STD

2.9. MARKET RESTRAINTS

2.9.1.   SIDE EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES

2.9.2.   LIMITED ACCESS TO CONTRACEPTIVES

2.10.            MARKET OPPORTUNITIES

2.10.1.                RISING DISPOSABLE INCOME IN EMERGING ECONOMIES

2.10.2.                UNMET MEDICAL NEEDS IN THE EMERGING ECONOMIES

2.10.3.                TECHNOLOGICAL ADVANCEMENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF ACCEPTANCE OF SOCIETY

3.    CONTRACEPTIVE MARKET OUTLOOK - BY EDUCATION

3.1. LESS THAN HIGH SCHOOL

3.2. HIGH SCHOOL GRADUATE

3.3. COLLEGE GRADUATE

3.4. OTHER COLLEGE DEGREES

4.    CONTRACEPTIVE MARKET OUTLOOK - BY AGE GROUP

4.1. 15–24 YEARS

4.2. 25–34 YEARS

4.3. 35–44 YEARS

4.4. ABOVE 44 YEARS

5.    CONTRACEPTIVE MARKET OUTLOOK - BY END USER

5.1. HOUSEHOLDS

5.2. CLINICS

5.3. HOSPITALS

6.    CONTRACEPTIVE MARKET OUTLOOK - BY DRUGS AND DEVICES

6.1. CONTRACEPTIVES DRUGS

6.1.1.   ORAL CONTRACEPTIVE PILLS

6.1.2.   INJECTABLE CONTRACEPTIVES

6.1.3.   TOPICAL CONTRACEPTIVES

6.2. CONTRACEPTIVE DEVICES

6.2.1.   MALE CONDOMS

6.2.2.   FEMALE CONDOMS

6.2.3.   DIAPHRAGMS

6.2.4.   CONTRACEPTIVE SPONGES

6.2.5.   VAGINAL RINGS

6.2.6.   SUBDERMAL IMPLANTS

6.2.7.   INTRA-UTERINE DEVICES

6.2.7.1.      COPPER INTRA-UTERINE DEVICES

6.2.7.2.      HORMONAL INTRA-UTERINE DEVICES

7.    CONTRACEPTIVE MARKET - REGIONAL OUTLOOK

7.1. NORTH AMERICA

7.1.1.   MARKET BY EDUCATION

7.1.2.   MARKET BY AGE GROUP

7.1.3.   MARKET BY END USER

7.1.4.   MARKET BY DRUGS & DEVICES

7.1.4.1.      MARKET BY DRUGS

7.1.4.2.      MARKET BY DEVICES

7.1.5.   COUNTRY ANALYSIS

7.1.5.1.      THE UNITED STATES

7.1.5.2.      CANADA

7.2. EUROPE

7.2.1.   MARKET BY EDUCATION

7.2.2.   MARKET BY AGE GROUP

7.2.3.   MARKET BY END USER

7.2.4.   MARKET BY DRUGS & DEVICES

7.2.4.1.      MARKET BY DRUGS

7.2.4.2.      MARKET BY DEVICES

7.2.5.   COUNTRY ANALYSIS

7.2.5.1.      GERMANY

7.2.5.2.      FRANCE

7.2.5.3.      THE UNITED KINGDOM

7.2.5.4.      SPAIN

7.2.5.5.      ITALY

7.2.5.6.      RUSSIA

7.2.5.7.      REST OF EUROPE

7.3. ASIA-PACIFIC

7.3.1.   MARKET BY EDUCATION

7.3.2.   MARKET BY AGE GROUP

7.3.3.   MARKET BY END USER

7.3.4.   MARKET BY DRUGS & DEVICES

7.3.4.1.      MARKET BY DRUGS

7.3.4.2.      MARKET BY DEVICES

7.3.5.   COUNTRY ANALYSIS

7.3.5.1.      JAPAN

7.3.5.2.      CHINA

7.3.5.3.      INDIA

7.3.5.4.      AUSTRALIA & NEW ZEALAND

7.3.5.5.      SOUTH KOREA

7.3.5.6.      ASEAN COUNTRIES

7.3.5.7.      REST OF ASIA-PACIFIC

7.4. LATIN AMERICA

7.4.1.   MARKET BY EDUCATION

7.4.2.   MARKET BY AGE GROUP

7.4.3.   MARKET BY END USER

7.4.4.   MARKET BY DRUGS & DEVICES

7.4.4.1.      MARKET BY DRUGS

7.4.4.2.      MARKET BY DEVICES

7.4.5.   COUNTRY ANALYSIS

7.4.5.1.      BRAZIL

7.4.5.2.      MEXICO

7.4.5.3.      REST OF LATIN AMERICA

7.5. THE MIDDLE EAST AND AFRICA

7.5.1.   MARKET BY EDUCATION

7.5.2.   MARKET BY AGE GROUP

7.5.3.   MARKET BY END USER

7.5.4.   MARKET BY DRUGS & DEVICES

7.5.4.1.      MARKET BY DRUGS

7.5.4.2.      MARKET BY DEVICES

7.5.5.   COUNTRY ANALYSIS

7.5.5.1.      UNITED ARAB EMIRATES

7.5.5.2.      TURKEY

7.5.5.3.      SAUDI ARABIA

7.5.5.4.      SOUTH AFRICA

7.5.5.5.      REST OF THE MIDDLE EAST & AFRICA

8.    COMPETITIVE LANDSCAPE

8.1. COMPANY PROFILES

8.1.1.   ALLERGAN INC.

8.1.2.   BAYER AG

8.1.3.   MELBEA

8.1.4.   PREGNA

8.1.5.   PFIZER, INC.

8.1.6.   CHURCH & DWIGHT CO., INC.

8.1.7.   AFAXYS, INC.

8.1.8.   APOTHECUS PHARMACEUTICAL CORPORATION

8.1.9.   COOPER SURGICAL INC

8.1.10.                OKAMOTO INDUSTRIES, INC

8.1.11.                MAYER LABORATORIES, INC.

8.1.12.                AGILE THERAPEUTICS

8.1.13.                MERCK & CO., INC.

8.1.14.                RECKITT BENCKISER PLC

8.1.15.                SMB CORPORATION

8.1.16.                TEVA PHARMACEUTICAL INDUSTRIES LTD.

8.1.17.                OCON MEDICAL LTD

9.    METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of table

TABLE 1        GLOBAL CONTRACEPTIVE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        CONTRACEPTIVE   MARKET PLAYER POSITIONING OUTLOOK 2017

TABLE 3        GLOBAL CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 5        GLOBAL CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 6        GLOBAL CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 7        GLOBAL CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        GLOBAL CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 9        GLOBAL INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 11      NORTH AMERICA CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 12      NORTH AMERICA CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 14      NORTH AMERICA CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 15      NORTH AMERICA CONTRACEPTIVE MARKET BY DRUGS 2019-2027 ($ MILLION)

TABLE 16      NORTH AMERICA CONTRACEPTIVE MARKET BY DEVICES 2019-2027 ($ MILLION)

TABLE 17      EUROPE CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 18      EUROPE CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 19      EUROPE CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 20      EUROPE CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 21      EUROPE CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 22      EUROPE CONTRACEPTIVE MARKET BY DRUGS 2019-2027 ($ MILLION)

TABLE 23      EUROPE CONTRACEPTIVE MARKET BY DEVICES 2019-2027 ($ MILLION)

TABLE 24      ASIA-PACIFIC CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 25      ASIA-PACIFIC CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 26      ASIA-PACIFIC CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 27      ASIA-PACIFIC CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 28      ASIA-PACIFIC CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 29      ASIA PACIFIC CONTRACEPTIVE MARKET BY DRUGS 2019-2027 ($ MILLION)

TABLE 30      ASIA PACIFIC CONTRACEPTIVE MARKET BY DEVICES 2019-2027 ($ MILLION)

TABLE 31      LATIN AMERICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 32      LATIN AMERICA CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 33      LATIN AMERICA CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 34      LATIN AMERICA CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 35      LATIN AMERICA CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 36      LATIN AMERICA CONTRACEPTIVE MARKET BY DRUGS 2019-2027 ($ MILLION)

TABLE 37      LATIN AMERICA CONTRACEPTIVE MARKET BY DEVICES 2019-2027 ($ MILLION)

TABLE 38      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 39      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 40      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 41      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 42      THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

TABLE 43      MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY DRUGS 2019-2027 ($ MILLION)

TABLE 44      MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET BY DEVICES 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      GLOBAL CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 2      PORTER’S FIVE FORCE MODEL

FIGURE 3      GLOBAL CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 28   THE UNITED STATES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 29   CANADA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 30   GERMANY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 31   FRANCE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 32   THE UNITED KINGDOM CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 33   SPAIN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 34   ITALY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 35   RUSSIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 36   REST OF EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 37   JAPAN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 38   CHINA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 39   INDIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 40   AUSTRALIA & NEW ZEALAND CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 41   SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 42   ASEAN COUNTRIES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 43   REST OF ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 44   BRAZIL CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 45   MEXICO CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 46   REST OF LATIN AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 47   UNITED ARAB EMIRATES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 48   TURKEY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 49   SAUDI ARABIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 50   SOUTH AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 51   REST OF THE MIDDLE EAST AND AFRICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;